Objective: To evaluate the skin changes of the neck of normal individuals after repeated applications of moderate-strength corticosteroid or tracrolimus ointment for 3 weeks by use of noninvasive biophysical measurements. Methods: A 0.12% betamethasone-17-valerate ointment or a 0.1% tacrolimus ointment was applied to the right side of the neck of 8 adult volunteers twice daily for 3 weeks together with control petrolatum applied to the left side of the neck for comparison. Biophysical skin measurements were performed on the neck skin before, 1 and 3 weeks after the start of the treatment and 1 week after the cessation of the treatment. Results: A decrease in hygroscopicity and water-holding capacity of the stratum corneum (SC) when evaluated with the in vivo water sorption-desorption test was found on the corticosteroid-ointment-treated side after 3 weeks of the treatment as compared with the petrolatum-treated side. The erythematous reaction to a topically applied 0.1% aqueous solution of methyl nicotinate, a vasodilator, appeared more slowly on the corticosteroid-ointment-treated skin than on the control skin. No such changes were observed on the skin treated with 0.1% tacrolimus ointment. Conclusion: Tacrolimus appears to cause few if any functional changes in the SC of healthy human skin because of its poor permeability into skin with an intact barrier function.

Keywords:
Tacrolimus, Corticosteroid, topical, Stratum corneum, Water-holding function, Noninvasive measurement
1.
Kolbe L, Kligman AM, Schreiner V, Stoudemayer T: Corticosteroid-induced atrophy and barrier impairment measured by noninvasive methods in human skin. Skin Res Technol 2001;7:73–77.
2.
Oikarinen A, Haapasaari KM, Sutinen M, Tasanen K: The molecular basis of glucocorticoid-induced skin atrophy: Topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo. Br J Dermatol 1998;139:1106–1110.
3.
Tagami H: Morphological and functional changes of the skin caused by topical corticosteroid application. Acta Dermatol (Kyoto) 1971–72;66–67:1–2.
4.
Leyden JJ, Thew M, Kligman AM: Steroid rosacea. Arch Dermatol 1974;110:619–622.
5.
Cotterill JA: Perioral dermatitis. Br J Dermatol 1979;101:259–262.
6.
Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, Harada S: Tacrolimus ointment for atopic dermatitis. Lancet 1994;344:883.
7.
Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H: Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br J Dermatol 1995;133:494–496.
8.
Kawakami T, Soma Y, Morita E, Koro O, Yamamoto S, Nakamura K, Tamaki K, Yajima K, Imaizumi A, Matsunaga R, Murakami N, Kashima M, Mizoguchi M: Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. Dermatology 2001;203:32–37.
9.
Tagami H, Ohi M, Iwatsuki K, Kanamaru Y, Yamada M, Ichijo B: Evaluation of the skin surface hydration in vivo by electrical measurement. J Invest Dermatol 1980;75:500–507.
10.
Tagami H, Kanamaru Y, Inoue K, Suehisa S, Inoue F, Iwatsuki K, Yoshikuni K, Yamada M: Water sorption-desorption test of the skin in vivo for functional assessment of the stratum corneum. J Invest Dermatol 1982;78:425–428.
11.
Kashibuchi N: Improved exfoliative cytology for morphological evaluation of skin. J Soc Cosmet Chemist Japan 1989;23:143–154.
12.
Tabata N, O’Goshi K, Zhen YX, Kligman AM, Tagami H: Biophysical assessment of persistent effects of moisturizers after their daily applications: Evaluation of corneotherapy. Dermatology 2000;200:308–313.
13.
Sheu HM, Lee JY, Kuo KW, Tsai JC: Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: Characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography. J Dermatol 1998;25:281–289.
14.
Sheu HM, Chang CH: Alterations in water content of the stratum corneum following long-term topical corticosteroids. J Formos Med Assoc 1991;90:664–669.
15.
Hachem JP, De Paepe K, Vanpee E, Kaufman L, Rogiers V, Roseeuw D: Combination therapy improves the recovery of the skin barrier function: An experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology 2001;202:314–319.
16.
Feldmann RJ, Maibach HI: Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol 1967;48:181–183.
17.
Lübbe J, Pournaras CC, Saurat JH: Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology 2000;201:249–251.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.